HomeLVTX • NASDAQ
LAVA Therapeutics NV
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.59M | -15.95% |
Net income | -3.48M | -472.20% |
Net profit margin | — | — |
Earnings per share | -0.12 | -531.65% |
EBITDA | -7.48M | -295.40% |
Effective tax rate | -6.91% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 66.56M | -29.62% |
Total assets | 71.16M | -28.18% |
Total liabilities | 45.37M | -6.28% |
Total equity | 25.78M | — |
Shares outstanding | 26.31M | — |
Price to book | 1.33 | — |
Return on assets | -24.96% | — |
Return on capital | -64.17% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -3.48M | -472.20% |
Cash from operations | -11.65M | -1,281.38% |
Cash from investing | 15.16M | 2,084.29% |
Cash from financing | — | — |
Net change in cash | 4.66M | 546.26% |
Free cash flow | -7.42M | -803.33% |
Previous close
$1.31
Day range
$1.29 - $1.33
Year range
$0.85 - $2.39
Market cap
34.33M USD
Avg Volume
31.69K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
CEO
Founded
2016
Website
Employees
34
